New articles in 2016

  • Erdei A, Sándor N, Mácsik-Valent B, Lukácsi S, Kremlitzka M, Bajtay Z. The versatile functions of complement C3-derived ligands. Immunol Rev. 2016 Nov;274(1):127-140. doi: 10.1111/imr.12498. Review

 

  • Kremlitzka M, Mácsik-Valent B, Erdei A. Regulation of B cell functions by Toll-like receptors and complement. Immunol Lett. 2016 Oct;178:37-44. doi: 10.1016/j.imlet.2016.07.015.

 

  • Kremlitzka M., Mácsik-Valent B., Polgár A., Kiss E., Poór G., Erdei A. Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients. Journal of Immunology Research, vol. 2016, Article ID 5758192, 10 pages, 2016. doi:10.1155/2016/5758192.

 

  • Huber K, Sármay G, Kövesdi D. MZ B cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10. Eur J Immunol. 2016 Sep;46(9):2239-46. doi: 10.1002/eji.201546248.

 

  • Orgovan N, Ungai-Salánki R, Lukácsi S, Sándor N, Bajtay Z, Erdei A, Szabó B, Horvath R. Adhesion kinetics of human primary monocytes, dendritic cells, and macrophages: Dynamic cell adhesion measurements with a label-free optical biosensor and their comparison with end-point assays. Biointerphases. 2016 Sep

 

  • Sándor N, Lukácsi S, Ungai-Salánki R, Orgován N, Szabó B, Horváth R, Erdei A, Bajtay Z. CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18. PLoS One. 2016 Sep 22;11(9):e0163120. doi: 10.1371/journal.pone.0163120.

 

  • Vince Kornél Grolmusz, Katalin Karászi, Tamás Micsik, Eszter Angéla Tóth, Katalin Mészáros, Gellért Karvaly, Gábor Barna, Péter Márton Szabó, Kornélia Baghy, János Matkó, Ilona Kovalszky, Miklós Tóth, Károly Rácz, Péter Igaz, Attila Patócs.  Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer. Am J Cancer Res 2016;6(9):2041-2053

 

  • Szittner Z, Bentlage AE, Rovero P, Migliorini P, Lóránd V, Prechl J, Vidarsson G. Label-free detection of immune complexes with myeloid cells. Clin Exp Immunol. 2016 Jul;185(1):72-80. doi: 10.1111/cei.12788.

 

  • Kecse-Nagy C, Szittner Z, Papp K, Hegyi Z, Rovero P, Migliorini P, Lóránd V, Homolya L, Prechl J. Characterization of NF-κB reporter U937 cells and their application for the detection of inflammatory immune-complexes. PLOS ONE 11:(5) Paper e0156328. 15 p. (2016)

 

  • Grolmusz VK, Tóth EA, Baghy K, Likó I, Darvasi O, Kovalszky I, Matkó J, Rácz K, Patócs A. Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression. BMC Genomics. 2016 May 27;17(1):412. doi: 10.1186/s12864-016-2747-6. PMID: 27234232

 

  • Mészáros T, Csincsi ÁI, Uzonyi B, Hebecker M, Fülöp TG, Erdei A, Szebeni J, Józsi M. Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro. Nanomedicine. 2016 May;12(4):1023-31.

 

  • Osteikoetxea-Molnár A, Szabó-Meleg E, Tóth EA, Oszvald Á, Izsépi E, Kremlitzka M, Biri B, Nyitray L, Bozó T, Németh P, Kellermayer M, Nyitrai M, Matko J. The growth determinants and transport properties of tunneling nanotube networks between B lymphocytes. Cell Mol Life Sci. 2016 Apr 28. [Epub ahead of print] PMID:27125884

 

  • Schneider AE, Sándor N, Kárpáti É, Józsi M. Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps. Mol Immunol. 2016 Apr;72:37-48.

 

  • Schmidt CQ, Harder MJ, Nichols EM, Hebecker M, Anliker M, Höchsmann B, Simmet T, Csincsi ÁI, Uzonyi B, Pappworth IY, Ricklin D, Lambris JD, Schrezenmeier H, Józsi M, Marchbank KJ. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients. Immunobiology. 2016 Apr;221(4):503-11.

 

  • Kurucz, I., Peter, B., Prosz, A., Szekacs, I., Horvath, R., & Erdei, A. Label-free optical biosensor for on-line monitoring the integrated response of human B cells upon the engagement of stimulatory and inhibitory immune receptors. Sensors and Actuators, B: Chemical, 240, 528-535. DOI: 10.1016/j.snb.2016.09.015

 

  • Prechl J, Papp K, Herincs Z, Peterfy H, Lorand V, Szittner Z, Estonba A, Rovero P, Paolini I, Del Amo J, Uribarri M, Alcaro MC, Ruiz-Larranaga O, Migliorini P, Czirjak L Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium. PLOS ONE 11:(3) p. e0150685.

 

  • Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome. Mol Immunol. 2016 Feb;70:47-55.

 

  • Pozsgay J, Szarka E, Huber K, Babos F, Magyar A, Hudecz F, Sarmay G. Synthetic Peptide-Based ELISA and ELISpot Assay for Identifying Autoantibody Epitopes. Methods Mol Biol. 2016;1352:223-33. doi: 10.1007/978-1-4939-3037-1_17.

 

  • Pozsgay J, Babos F, Uray K, Magyar A, Gyulai G, Kiss É, Nagy G, Rojkovich B, Hudecz F, Sármay G. In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles. Arthritis Res Ther. 2016 Jan 16;18:15. doi: 10.1186/s13075-016-0918-0.
2016.01.01.